Significant funding for Turku Bioscience research groups
We are delighted to announce that Professors Riitta Lahesmaa and Johanna Ivaska have received funding from Syöpäsäätiö. Warmest congratulations!
Prof. Johanna Ivaska and her research group received 450 000 € (three years grant) for research topic Receptor sorting and cytoskeletal regulation in breast cancer.
Prof Riitta Lahesmaa and her research group received 50 000 € (one year grant) for research topic STAT3-mediated molecular mechanism in cancer
Prof. Johanna Ivaska’s funding was significant so it was also widely recognized by Finnish press:
Lahjoittajien avulla uusi ennätys: 7,3 miljoonaa euroa syöpätutkimukseen [Syöpäsäätiö]
Syöpäsäätiö jakoi lähes 7,3 miljoonaa euroa tutkimukseen – Turun yliopiston professori Johanna Ivaskan työryhmälle 450 000 euroa [Turun Sanomat]
Johanna Ivaskalle Syöpäsäätiön suurapuraha 450 000 euroa [Turun yliopisto]
Professori Johanna Ivaskan tutkimusryhmälle 450 000 euroa Syöpäsäätiöltä [Aamuset]
Syöpäsäätiö jakanut ennätyksellisesti tukea syöpätutkimukseen [Lääkärilehti]
Recent Posts
- Dissertation Defence: Eleftheria MaranouMSc Eleftheria Maranou, from affiliated MIORG group, succesfully defended the dissertation in Immunology titled “The Achilles’ heel of Read moreSeptember 1, 2026
- Researchers discover molecular mechanism that helps aggressive colorectal cancer to spreadResearchers from the University of Turku in Finland, Turku Bioscience Centre and Gustave Roussy Institute Read moreAugust 25, 2026
- The Novo Nordisk Foundation has awarded funding of approximately one million euros to a research project led by Professor Jukka WestermarckThe Novo Nordisk Foundation has awarded funding of approximately one million euros to a research Read moreAugust 21, 2026
- The Jane and Aatos Erkko Foundation has granted nearly €1 million to support research led by Professor Jukka Westermarck993 000 € was granted to a research project led by our Group Leader Professor Jukka Read moreApril 2, 2026
- Cecilia Sahlgren’s group discovers a new mechanism driving breast cancer progressionOur affiliated research group led by Professor Cecilia Sahlgren at Åbo Akademi University and the InFLAMES Research Read moreMarch 25, 2026
- BioCity Turku asks for proposals for Elias Tillandz publication prize winner during March 2026In the context of the 35th BioCity Symposium “Vision, Expanded” (27-28 August 2026) the twenty-second Read moreMarch 3, 2026